|
Diversified Employee Benefit Services, LLC |
 |
|
|
| Sign-up today to start receiving
The HCB Newsletter! |
 | |
|
| Welcome!
To San Antonio's newest online healthcare and bioscience community and to The HCB Newsletter, feeder publication to the S.A. HC+B website and the upcoming San Antonio Healthcare & Bioscience Magazine, www.hcbmagazine.com.
In this week's issue read about Conceptual Mindwork's new online patient portal, Dr. Winakur gets published, the FDA approves Genzyme, and BAMC gets a little help from robots in the field.
I hope everyone had a long and restful holiday.
Best!
Melba Romero
Publisher/Editor
S.A. Healthcare & Bioscience Magazine |
Sevocity Unveils New, Secure, Online Patient Portal for Doctor-Patient Communication |
 New Patient Portal will be Provided Free to Sevocity Customers as part of Sevocity EHR 5.2
San Antonio, TX - Sevocity, a division of Conceptual MindWorks, Inc. (CMI), recently announced the launch of Sevocity Patient Portal, a secure web portal that will allow Sevocity EHR (electronic health record) clients to seamlessly and securely communicate with patients via the internet. The Patient Portal is included in Sevocity TM EHR 5.2, the newest release of the Sevocity electronic health record solution. Full Story. |
|
Dr. Jerald Winakur and Hyperion Press Announce Release of New Book |
 MEMORY LESSONS: A Doctor's Story (Hyperion/January 1, 2009/$ 24.95) is an honest and courageous account of Dr. Jerald Winakur's father's last years, the life he slowly forgot, and what a family faces when dementia begins destroying memory after memory, ability after ability.
The Center for Medical Humanities & Ethics and Pasteur Medical Associates present: MEMORY LESSONS: A Doctor's StoryJerald Winakur, MD, FACP, CMD Thursday, January 22, 2009, 6:00-7:00 pm Reception and Book Signing: 7:00-8:00 pm UT Health Science Center San Antonio 7703 Floyd Curl Dr., RM. 3.102 (Next to the Briscoe Library) |
|
Hospital Robot Helps to Save Lives Off Battlefield |
 American Forces Press Service, WASHINGTON, Dec. 5, 2008Once confined solely to the pages of science fiction, remotely controlled robots are now commonplace on today's battlefield, extending the reach of bomb experts and being used extensively to search for and destroy booby traps intent on killing U.S. troops. Remotely piloted aircraft also have proven their worth in combat, and now are in high demand, allowing the U.S. military to project its firepower and reconnaissance capabilities beyond its troops' reach. Full Story. |
|
FDA Approves Genzyme's Mozobil |
 Genzyme Corporation, San Antonio, TX - December 15, 2008 Product Provides Enhanced Mobilization of Stem Cells for Autologous Transplantation in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
Genzyme Corporation (Nasdaq: GENZ) announced today that the U.S. Food and Drug Administration has granted marketing approval for Mozobil™ (plerixafor injection), a drug intended to be used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM). The product has also been granted orphan drug designation. Full Story. |
|
|
|
|
